By Peter J. Pitts President Donald Trump just announced a sweeping executive order that’d forbid Medicare from paying more for advanced medicines than any other developed country. This price control scheme, if implemented, would sound a death knell for medical innovation – and potentially for many patients. Drug development is expensive, time-consuming and full of […]

The post Price Controls Rob Patients of Future Therapies first appeared on The Madison Times.